Rubius Therapeutics, Inc. - Common Stock (NY:ONLN)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Alibaba Jumps Post Q3 Earnings: ETFs To Buy
February 23, 2025
Dan Loeb's Amazon Stake Moves: A Look At His Trading Shifts
February 12, 2025
Amazon Cuts More Jobs in Cost-Saving Push: Report
January 30, 2025
AskSlim Market Week - Friday, Dec. 20
December 20, 2024
eBay Expands Klarna Partnership: Buy Now, Pay Later Goes Big In Europe
December 13, 2024
US-Listed Chinese Stocks Give Up Gains In Anticipation Of More Stimulus
December 12, 2024
5 ETFs For Smart Holiday Season Investing
December 09, 2024
Amazon's AWS CEO Teases Major AI Advancements
December 02, 2024
Alibaba Co-Founder Jack Ma Makes Rare Appearance At Company Campus
November 29, 2024
Amazon ETFs Set To Surge On Q3 Earnings Beat
November 02, 2024
Frequently Asked QuestionsIs Rubius Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rubius Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rubius Therapeutics, Inc. - Common Stock trade on?
Rubius Therapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rubius Therapeutics, Inc. - Common Stock?
The ticker symbol for Rubius Therapeutics, Inc. - Common Stock is ONLN on the New York Stock Exchange
What is the current price of Rubius Therapeutics, Inc. - Common Stock?
The current price of Rubius Therapeutics, Inc. - Common Stock is 43.19
When was Rubius Therapeutics, Inc. - Common Stock last traded?
The last trade of Rubius Therapeutics, Inc. - Common Stock was at 03/31/25 01:30 PM ET
What is the market capitalization of Rubius Therapeutics, Inc. - Common Stock?
The market capitalization of Rubius Therapeutics, Inc. - Common Stock is 669.45K
How many shares of Rubius Therapeutics, Inc. - Common Stock are outstanding?
Rubius Therapeutics, Inc. - Common Stock has 669K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|